Global Brain And Neuroimaging Devices Market Growth Drivers 2024, Forecast To 2033
9 Jan, 2024
The brain and neuroimaging devices market has exhibited strong growth, increasing from $37.53 billion in 2023 to $39.66 billion in 2024, achieving a 5.7% CAGR. Historical growth is attributed to the diagnosis and treatment of neurological disorders, an aging population, brain mapping and connectivity research, and emerging market growth. Future growth is anticipated, with the market poised to reach $48.66 billion by 2028, sustaining a 5.2% CAGR. Drivers for this growth include regulatory support, personalized medicine,
Global Brain And Neuroimaging Devices Market Key Driver
The incidence of neurological disorders is rising, creating a market demand. The European Academy of Neurology reports that one in three people is affected by a neurological disease in 2022. Neuroimaging devices play a crucial role in diagnosis, enhancing survival rates and disease management. The increasing incidence is expected to drive the brain and neuroimaging devices market.
Get A Free Sample Of The Global Brain And Neuroimaging Devices Market ReportGlobal Brain And Neuroimaging Devices Market Segments
The brain and neuroimaging devices market covered in this report is segmented –
1) By Imaging Type: Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Other Imaging Types
2) By Application: Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Other Applications
3) By End-user: Hospitals, Diagnostic Centres, Ambulatory Surgical Centres
By Geography: The regions covered in the brain and neuroimaging devices market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
Western Europe was the largest region in the brain and neuroimaging devices market in 2023. North America was the second-largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in the brain and neuroimaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Brain And Neuroimaging Devices Industry Players
GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, Medtronic Plc., EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Varian Medical Systems, Toshiba Corporation, Shimadzu Corporation, Agilent Technologies Inc., Waters Corporation, Bruker Corporation, PerkinElmer Inc., Luminex Corporation, Bio-Rad Laboratories Inc., Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Hologic Inc., Nihon Kohden Corporation, Natus Medical Incorporated, RIMED Ltd., Advanced Brain Monitoring Inc., Intranerve Neuroscience Holdings LLC., Nuvasive Inc., SpecialtyCare Inc.
Get The Full Global Brain And Neuroimaging Devices Market Report
Brain And Neuroimaging Devices Market Overview
Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders.
Brain And Neuroimaging Devices Global Market Report 2023 provides data on the global brain and neuroimaging devices market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The brain and neuroimaging devices market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.